fbpx How many B antigens should a good influenza vaccine have? | Science in the net

How many B antigens should a good influenza vaccine have?

di redazione
Pubblicato il 27/12/2013Read time: 2 mins
Global Health
Vaccine

The vaccine against seasonal influenza is called trivalent, because it contains viruses representing three influenza strains: one A/H1N1, one A/H3N2, and one B. the single B-lineage antigen included is the one that is predicted to circulate in the related season. However, this means that some mismatch between the B antigen in the vaccine and the B antigen actually circulating may occur, this being a problem since cross-protection by immunization against the other lineage is expected to be low.

In order to minimize such mismatch, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) suggested using quadrivalent vaccines that include both influenza B virus antigenic lineages, called Victoria and Yamagata. A study published on Vaccine estimated the benefit that a quadrivalent vaccine could bring compared to a trivalent one, concluding that the additional protection provided by including a second lineage of influenza B could result in a modest reduction in influenza-associated outcomes.

Another study, published on the New England Journal of Medicine, evaluated the efficacy of a candidate inactivated quadrivalent influenza vaccine in children 3 to 8 years of age. Their results provided evidence that the quadrivalent vaccine tested prevents influenza associated with the A/H1N1, A/H3N2, and B Victoria strains individually. The low number of B Yamagata confirmed infections did not allow to properly estimate the efficacy of the vaccine against this strain but the immune response was high enough to suggest a similar efficacy against other strains.


Scienza in rete è un giornale senza pubblicità e aperto a tutti per garantire l’indipendenza dell’informazione e il diritto universale alla cittadinanza scientifica. Contribuisci a dar voce alla ricerca sostenendo Scienza in rete. In questo modo, potrai entrare a far parte della nostra comunità e condividere il nostro percorso. Clicca sul pulsante e scegli liberamente quanto donare! Anche una piccola somma è importante. Se vuoi fare una donazione ricorrente, ci consenti di programmare meglio il nostro lavoro e resti comunque libero di interromperla quando credi.


  • 9341 reads

prossimo articolo

The embarrassing Covid

di Stefania Salmaso
Pubblicato il 02/10/2023

There's a certain discomfort in having to talk about Covid-19 again, as demanded by the increase in cases that is also recorded in Italy. The reason, writes epidemiologist Stefania Salmaso, might perhaps be identified in the lack of a transparent process that allows understanding on what basis the health authority formulates recommendations, leading to reliance on pundits.

Image credits: visuals/Unsplash

Epidemiology

“An embarrassing Covid-19”: It could be the title of a short story by Calvino or a rhyme by Rodari, but it's what we're witnessing these days. The increasing frequency of SARS-CoV-2 infections in various areas of the world, including Italy, has forced mainstream media to address it again. However, it's often discussed with a sort of embarrassment and only for the sake of reporting. When discussing possible countermeasures, the discomfort becomes even more apparent.